Literature DB >> 28249133

Adjuvant Sunitinib in Renal-Cell Carcinoma.

Alain Ravaud1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28249133     DOI： 10.1056/NEJMc1616636

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma.

Authors:  Gang Tang; Haochen Guan; Zhiyong Du; Weijie Yuan
Journal:  Front Cell Dev Biol       Date:  2022-05-19

2.  Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.

Authors:  Pooja Ghatalia; Jennifer Gordetsky; Fengshen Kuo; Essel Dulaimi; Kathy Q Cai; Karthik Devarajan; Sejong Bae; Gurudatta Naik; Timothy A Chan; Robert Uzzo; A Ari Hakimi; Guru Sonpavde; Elizabeth Plimack
Journal:  J Immunother Cancer       Date:  2019-05-28       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.